AlphAIalphai — Financial news for AI agents
SEC EDGARJUL 312 min read$VRSK

Shavel Lee sold $550K of VRSK

Shavel Lee (Chief Executive Officer) sold 2,500 shares of Verisk Analytics, Inc. (VRSK) at $220.00 ($0.55M total) on 2026-07-29 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Shavel Lee
Published Jul 31, 2026, 8:05 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 31, 2026, 8:28 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefInsider activity
Primary signal
$VRSK
Neutral
high confidence
Mentioned
$VRSK
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VRSKNeutralLow
01

Why it matters

Because the text contains no new business, financial, or regulatory information beyond the transaction mechanics, the trading impact should be limited to sentiment and positioning rather than fundamentals.

02

Market read

Traders may note the insider sale for sentiment, but there is no new catalyst to drive a durable repricing.

03

What to watch

The article provides only the sale details; it does not include total planned volume, prior sales cadence, or whether other insiders bought/sold around the same period.

Relevance 4/10Novelty 3/10Timing: Filed on 2026-07-31 after-hours; reflects sale executed 2026-07-29.

Background

The article is a SEC Form 4 insider transaction for Verisk Analytics, reporting an open-market sale by the CEO under a pre-arranged 10b5-1 plan.

Company-level read

Ticker impact

$VRSKNeutralHigh confidence
Context

Verisk CEO Shavel Lee filed a Form 4 open-market sale of 2,500 shares at $220 on 2026-07-29 under a 10b5-1 plan.

Expected impact

Low near-term impact; any reaction is likely limited to short-lived sentiment noise.

Evidence & confidence

The filing is an open-market sale under a pre-arranged 10b5-1 plan, with no accompanying guidance, deal, or regulatory development in the text.

Market effects

Sector

Minimal, as the disclosure is company-specific and does not indicate sector-wide regulatory or demand changes.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

Even with a 10b5-1 plan, repeated insider selling can be read by some traders as a mild confidence signal, especially if paired with other negative news not present here.

Key entities

  • issuer
    Verisk Analytics, Inc.

    Subject of the Form 4 insider transaction disclosure.

  • insider
    Shavel Lee

    CEO and director who executed the reported open-market sale under a 10b5-1 plan.

Read at source← All news

Related articles

AUG 8
$VRSKMedAI 8/10

Verisk Analytics (VRSK) Q2 2026 Earnings Call Transcript

Verisk Analytics (NASDAQ:VRSK) reported Q2 2026 revenue of $806 million, up 4.3% reported and 5.8% organic constant currency. Adjusted EBITDA was $464 million, up 7.4% on the same basis. Subscription revenue was 83% of total, and diluted adjusted EPS was $1.98. Full-year guidance was reaffirmed: revenue $3.19B to $3.24B and EPS $7.45 to $7.75.

aol.com6 min
AUG 7
$VRSKMedAI 8/10

Verisk Ordered to Move Ahead With $2.35 Billion AccuLynx Merger

A Delaware Chancery Court judge ordered Verisk Analytics to proceed with its $2.35 billion merger with AccuLynx, rejecting AccuLynx’s bid to raise the deal price over antitrust clearance concerns. The judge cited willful conduct by AccuLynx for a failed closing condition and awarded AccuLynx damages for direct costs plus interest. The deal still requires HSR Act clearance and FTC approval.

news.bloomberglaw.com4 min
JUL 29
$VRSKMedAI 8/10

[VRSK Q2 2026 Earnings Call] Verisk Q2 Organic Revenue Hits 5.8% as XactAI Users Jump 10x to 7,000, but Transactional Drag Persists — BigGo Finance

Verisk Analytics (VRSK) reported Q2 2026 revenue of $806 million, up 5.8% organic constant currency, driven by 8% subscription growth (83% of revenue). Transactional revenue fell 4.2% due to softer commercial property quotes and weaker weather demand. XactAI users rose 10x to 7,000. Full-year guidance of $3.19–$3.24B revenue and $1.79–$1.83B adj. EBITDA was reaffirmed.

finance.biggo.com7 min
JUL 29
$VRSKMed

Verisk Vaults on Releasing Q2 Results

Verisk (NASDAQ: VRSK) reported Q2 results for the quarter ended June 30, 2026. Net income fell 9.8% to $229 million, citing higher tax rate, net interest expense, and legal fees tied to litigation. The company paid a $0.50 dividend per share and launched a $200 million accelerated share repurchase, with an initial delivery of 949,190 shares at $179.10. Shares rose 9.6% to $221.87.

baystreet.ca3 min